Protocol Status: PUBLISHED
Protocol:
Version: 2026.01
Effective Date:
Last Reviewed:
Medical Director Approval:
Clinical Note: This content reflects current GCEMS clinical guidelines as of the dates listed above. If content appears inconsistent with current policy, use the most recent approved guideline and notify leadership for correction.

Diazepam

(Valium)

 

GCEMS Protocol:

 

  • Alternate to Lorazepam in cases of drug shortage

 

INDICATIONS:

 

  • Major motor seizures
  • Status epilepticus
  • Pre-medication prior to cardioversion, transcutaneous pacing
  • Skeletal muscle relaxant
  • Acute anxiety states
  • Medication for combative patients and difficult intubations

 

DOSAGE:

 

ADULT:

 

  • 1-5 mg IV/IO/IM to a maximum of 10 mg

 

PEDIATRIC:

 

  • 0.2 mg/kg IV/IO/IM titrated to a single max dose of 5 mg; may be repeated once every five minutes to a total maximum dose of 10 mg

 

CONTRAINDICATIONS:

 

  • Respiratory depression

 

SIDE EFFECTS:

 

  • Respiratory/Cardiac arrest
  • Decreased LOC
  • Hypotension